The vector of anti-EGP-2 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human EGP-2. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-EGP-2 antibody linked to CD28 signaling domains. And the vector product was designed for the treatment of EGP-2+ colon cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-T-2-M316-4G||Anti-EGP-2 scFv h(CD4-FcεRIγ) CART, pCDCAR1|
|CAR-MZ151||Anti-EpCAM (M13-57) h(CD3ζ) CAR, pCDCAR1|
|VP-CAR-LC212||Lenti-EGP-2 CAR (scFv-CD28-FcεRIγ, GA733.2) Viral Particle|
|CAR-T-2-M316-4Z||Anti-EGP-2 scFv h(CD4-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC215||Lenti-EGP-2 CAR (scFv-CD4-CD3ζ, GA733.2) Viral Particle|
|CAR-MZ153||Anti-EpCAM (M13-57) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-T-1-M316-G||Anti-EGP-2 scFv h(FcεRIγ) CART, pCDCAR1|
|VP-CAR-LC664||Lenti-EpCAM CAR (scFv-CD28-41BB-CD3ζ) Viral Particle|
|VP-CAR-LC218||Lenti-EGP-2 CAR (scFv-b2c-CD3ζ, GA733.2) Viral Particle|
|CAR-LC181||Anti-EpCAM h(CD28-41BB-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved